These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Gait Speed Predicts 30-Day Mortality After Transcatheter Aortic Valve Replacement: Results From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. Alfredsson J; Stebbins A; Brennan JM; Matsouaka R; Afilalo J; Peterson ED; Vemulapalli S; Rumsfeld JS; Shahian D; Mack MJ; Alexander KP Circulation; 2016 Apr; 133(14):1351-9. PubMed ID: 26920495 [TBL] [Abstract][Full Text] [Related]
8. Two-Year Outcomes in Patients With Severe Aortic Valve Stenosis Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: The All-Comers Nordic Aortic Valve Intervention Randomized Clinical Trial. Søndergaard L; Steinbrüchel DA; Ihlemann N; Nissen H; Kjeldsen BJ; Petursson P; Ngo AT; Olsen NT; Chang Y; Franzen OW; Engstrøm T; Clemmensen P; Olsen PS; Thyregod HG Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27296202 [TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of baseline 6-min walk test performance in intermediate risk patients undergoing transcatheter aortic valve replacement. Sathananthan J; Green P; Finn M; Wood DA; Lauck S; Crowley A; Alu M; Arnold SV; Cohen D; Kapadia S; Mack M; Thourani VH; Kodali S; Leon M; Webb JG Catheter Cardiovasc Interv; 2021 Jan; 97(1):E154-E160. PubMed ID: 32521123 [TBL] [Abstract][Full Text] [Related]
10. Long-term Outcomes of Transcatheter Aortic Valve Replacement With the Lotus Valve vs CoreValve/EvolutR: A Secondary Analysis of the REPRISE III Randomized Clinical Trial. Rizik DG; Rajagopal V; Makkar RR; Bajwa T; Kleiman NS; Linke A; Kereiakes DJ; Waksman R; Thourani VH; Stoler RC; Mishkel GJ; Iyer VS; Buchbinder M; Götberg M; Bjursten H; Allocco DJ; Reardon MJ JAMA Netw Open; 2022 Oct; 5(10):e2238792. PubMed ID: 36301543 [TBL] [Abstract][Full Text] [Related]
11. Frailty and Bleeding in Older Adults Undergoing TAVR or SAVR: Insights From the FRAILTY-AVR Study. Bendayan M; Messas N; Perrault LP; Asgar AW; Lauck S; Kim DH; Arora RC; Langlois Y; Piazza N; Martucci G; Lefèvre T; Noiseux N; Lamy A; Peterson MD; Labinaz M; Popma JJ; Webb JG; Afilalo J JACC Cardiovasc Interv; 2020 May; 13(9):1058-1068. PubMed ID: 32381184 [TBL] [Abstract][Full Text] [Related]
14. Inclusion of Functional Status Measures in the Risk Adjustment of 30-Day Mortality After Transcatheter Aortic Valve Replacement: A Report From the Society of Thoracic Surgeons/American College of Cardiology TVT Registry. Arnold SV; O'Brien SM; Vemulapalli S; Cohen DJ; Stebbins A; Brennan JM; Shahian DM; Grover FL; Holmes DR; Thourani VH; Peterson ED; Edwards FH; JACC Cardiovasc Interv; 2018 Mar; 11(6):581-589. PubMed ID: 29566805 [TBL] [Abstract][Full Text] [Related]
15. Outcomes of Patients With Severe Symptomatic Aortic Valve Stenosis After Chest Radiation: Transcatheter Versus Surgical Aortic Valve Replacement. Zhang D; Guo W; Al-Hijji MA; El Sabbagh A; Lewis BR; Greason K; Sandhu GS; Eleid MF; Holmes DR; Herrmann J J Am Heart Assoc; 2019 May; 8(10):e012110. PubMed ID: 31124737 [TBL] [Abstract][Full Text] [Related]
16. The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience. Green P; Woglom AE; Genereux P; Daneault B; Paradis JM; Schnell S; Hawkey M; Maurer MS; Kirtane AJ; Kodali S; Moses JW; Leon MB; Smith CR; Williams M JACC Cardiovasc Interv; 2012 Sep; 5(9):974-81. PubMed ID: 22995885 [TBL] [Abstract][Full Text] [Related]